| Cvs Pharmacy #00686 | |
| 178 Washington Street, Braintree, Massachusetts 02184 | |
| (781) 843-0731 |
| Name | Cvs Pharmacy #00686 |
|---|---|
| Organization Name | Cvs Pharmacy Inc |
| Location | 178 Washington Street, Braintree, Massachusetts 02184 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (781) 843-0731 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
The U.S. Food and Drug Administration today approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
To unravel the mysterious mechanisms of drug potency for the treatment of cardiac arrhythmias, a group of researchers at UC Davis have developed novel simulations that provide insights on vital atomic-scale drug-cardiac cells interactions.
Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.
› Verified 5 days ago
| NPI Number | 1184723546 |
| Organization Name | CVS PHARMACY INC |
| Doing Business As | CVS PHARMACY# 00686 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 178 Washington St, Braintree, MA 02184 |
| Phone Number | 617-773-0558 |
News Archive
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
The U.S. Food and Drug Administration today approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
To unravel the mysterious mechanisms of drug potency for the treatment of cardiac arrhythmias, a group of researchers at UC Davis have developed novel simulations that provide insights on vital atomic-scale drug-cardiac cells interactions.
Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.
› Verified 5 days ago
News Archive
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
The U.S. Food and Drug Administration today approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
To unravel the mysterious mechanisms of drug potency for the treatment of cardiac arrhythmias, a group of researchers at UC Davis have developed novel simulations that provide insights on vital atomic-scale drug-cardiac cells interactions.
Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.
› Verified 5 days ago
Cvs Pharmacy #17600 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 250 Granite St, Braintree, Massachusetts 02184 Phone: (781) 817-8810 | |
Cvs Pharmacy #00686 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 178 Washington Street, Braintree, Massachusetts 02184 Phone: (781) 843-0731 | |
Cvs Pharmacy #01861 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 884-886 Washington Street, Braintree, Massachusetts 02184 Phone: (781) 843-0648 | |
Cvs Pharmacy # 01297 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 270 Grove Street, Braintree, Massachusetts 02184 Phone: (781) 356-0714 | |
Walgreens #17228 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11 Pearl St, Braintree, Massachusetts 02184 Phone: (781) 356-3337 |